David Sinclair and Longevity: The Documented Public Record
A clinical review of David Sinclair's publicly confirmed use of NMN, metformin, and resveratrol for longevity, with peer-reviewed context on each compound's mechanisms and evidence base.
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 8 of 8 clinical reviews.
A clinical review of David Sinclair's publicly confirmed use of NMN, metformin, and resveratrol for longevity, with peer-reviewed context on each compound's mechanisms and evidence base.
How David Sinclair's confirmed NMN, metformin, and resveratrol regimen compares to other public longevity advocates, with clinical context from the HealthRX.com Medical Team.
A clinical timeline of David Sinclair's publicly documented longevity regimen, including NMN, metformin, and resveratrol, with peer-reviewed medical context for each intervention.
Harvard longevity researcher David Sinclair has publicly confirmed taking NMN, metformin, and resveratrol for years. The HealthRX.com Medical Team examines what clinical evidence says about stopping or continuing these compounds long-term.
Harvard geneticist David Sinclair has openly shared his NMN, metformin, and resveratrol regimen. The HealthRX.com Medical Team maps his reported side effects against peer-reviewed clinical data.
Harvard geneticist David Sinclair has publicly detailed his use of NMN, metformin, and resveratrol for longevity. The HealthRX.com Medical Team breaks down what his regimen means for non-celebrity patients.
A clinical and financial breakdown of the NMN, metformin, and resveratrol regimen David Sinclair has publicly confirmed taking, with real-world cost and access data for everyday patients.
Harvard longevity scientist David Sinclair has publicly confirmed taking NMN, metformin, and resveratrol. We translate that public record into real clinical context: mechanisms, dosing, evidence, and the honest gaps in what we actually know.